Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 4/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HTR6 | P50406 | 3/20 | 0.39 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.37 |
| ▸ | RORC | P51449 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2831091 | 0.94 | SMN1; SMN2 (0.43) | SLC6A2SLC6A4SLC6A3SMN1; SMN2HTR6 | |
| SCHEMBL1958272 | 0.89 | KMT2A (0.42) | SLC6A2SLC6A4SLC6A3SMN1; SMN2HTR6 | |
| SCHEMBL1955377 | 0.85 | LTA4H (0.53) | SLC6A2SLC6A4SLC6A3HTR6LTA4H | |
| SCHEMBL17893686 | 0.81 | ALDH1A1 (0.47) | SMN1; SMN2KDM4EALDH1A1KMT2AMEN1 | |
| SCHEMBL16056102 | 0.78 | ALDH1A1 (0.49) | SMN1; SMN2KDM4EALDH1A1KMT2AMEN1 | |
| SCHEMBL16055437 | 0.78 | HIF1A (0.41) | SMN1; SMN2ALDH1A1KMT2AMEN1POLB | |
| Tert-Butyl Formate SCHEMBL27850274 | 0.77 | LTA4H (0.44) | SLC6A2SLC6A4SLC6A3HTR6LTA4H | |
| SCHEMBL1957162 | 0.76 | CYP2C9 (0.47) | SMN1; SMN2HTR6KDM4EALDH1A1KMT2A | |
| SCHEMBL27910608 | 0.76 | MAPT (0.51) | SMN1; SMN2HTR6KDM4EALDH1A1KMT2A | |
| SCHEMBL17893671 | 0.76 | PRKDC (0.53) | SMN1; SMN2KDM4EALDH1A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2507229-A1 | SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES | Abbott Laboratories (US) | 2012-10-10 | — | — | EP | disclosed |
| EP-2376480-A2 | SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES | Abbott Laboratories (US) | 2011-10-19 | — | — | EP | disclosed |
| WO-2011068561-A1 | SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES | ABBOTT LABORATORIES (US) | 2011-06-09 | — | — | WO | disclosed |
| WO-2010065865-A2 | BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES | ABBOTT LABORATORIES (US) | 2010-06-10 | — | — | WO | disclosed |